[1] LIU CM, DING LJ, LI JY, et al. Advances in the study of ovarian dysfunction with aging. Yi Chuan. 2019;41(9):816-826.
[2] CONNELLY PJ, MARIE FREEL E, PERRY C, et al. Gender-Affirming Hormone Therapy, Vascular Health and Cardiovascular Disease in Transgender Adults. Hypertension. 2019;74(6):1266-1274.
[3] BOUET PE, BOUEILH T, DE LA BARCA JMC, et al. The cytokine profile of follicular fluid changes during ovarian ageing. J Gynecol Obstet Hum Reprod. 2020;49(4):101704.
[4] YANG X, WANG W, ZHANG Y, et al. Moxibustion improves ovary function by suppressing apoptosis events and upregulating antioxidant defenses in natural aging ovary. Life Sci. 2019;229:166-172.
[5] TURAN V, OKTAY K. BRCA-related ATM-mediated DNA double-strand break repair and ovarian aging. Hum Reprod Update. 2020;26(1):43-57.
[6] SHEIKHANSARI G, AGHEBATI-MALEKI L, NOURI M, et al. Current approaches for the treatment of premature ovarian failure with stem cell therapy. Biomed Pharmacother. 2018;102:254-262.
[7] YANG W, ZHANG J, XU B, et al. HucMSC-Derived Exosomes Mitigate the Age-Related Retardation of Fertility in Female Mice. Mol Ther. 2020;28(4):1200-1213.
[8] WANG Z, YANG T, LIU S, et al. Effects of bone marrow mesenchymal stem cells on ovarian and testicular function in aging Sprague-Dawley rats induced by D-galactose. Cell Cycle. 2020;19(18):2340-2350.
[9] ZHANG C. The Roles of Different Stem Cells in Premature Ovarian Failure. Curr Stem Cell Res Ther. 2020;15(6):473-481.
[10] DING C, LI H, WANG Y, et al. Different therapeutic effects of cells derived from human amniotic membrane on premature ovarian aging depend on distinct cellular biological characteristics. Stem Cell Res Ther. 2017;8(1):173.
[11] HUANG B, DING C, ZOU Q, et al. Human Amniotic Fluid Mesenchymal Stem Cells Improve Ovarian Function During Physiological Aging by Resisting DNA Damage. Front Pharmacol. 2020;11:272.
[12] DING C, ZOU Q, WU Y, et al. EGF released from human placental mesenchymal stem cells improves premature ovarian insufficiency via NRF2/HO-1 activation. Aging (Albany NY). 2020;12(3):2992-3009.
[13] HAN Y, LI X, ZHANG Y, et al. Mesenchymal Stem Cells for Regenerative Medicine. Cells. 2019;8(8):886.
[14] PAN XH, CHEN YH, YANG YK, et al. Relationship between senescence in macaques and bone marrow mesenchymal stem cells and the molecular mechanism. Aging (Albany NY). 2019;11(2):590-614.
[15] PAN XH, HUANG X, RUAN GP, et al. Umbilical cord mesenchymal stem cells are able to undergo differentiation into functional islet-like cells in type 2 diabetic tree shrews. Mol Cell Probes. 2017;34:1-12.
[16] PAN XH, LIN QK, YAO X, et al. Umbilical cord mesenchymal stem cells protect thymus structure and function in aged C57 mice by downregulating aging-related genes and upregulating autophagy- and anti-oxidative stress-related genes. Aging (Albany NY). 2020; 12(17):16899-16920.
[17] GUO DB, ZHU XQ, LI QQ, et al. Efficacy and mechanisms underlying the effects of allogeneic umbilical cord mesenchymal stem cell transplantation on acute radiation injury in tree shrews. Cytotechnology. 2018;70(5):1447-1468.
[18] PAN XH, ZHOU J, YAO X, et al. Transplantation of induced mesenchymal stem cells for treating chronic renal insufficiency. PLoS One. 2017;12(4): e0176273.
[19] WEIDNER L, GÄNSDORFER S, UNTERWEGER S, et al. Quantification of SARS-CoV-2 antibodies with eight commercially available immunoassays. J Clin Virol. 2020;129:104540.
[20] BEHNKE J, KREMER S, SHAHZAD T, et al. MSC Based Therapies-New Perspectives for the Injured Lung. J Clin Med. 2020;9(3):682.
[21] CASTILLA-CASADIEGO DA, REYES-RAMOS AM, DOMENECH M, et al. Effects of Physical, Chemical, and Biological Stimulus on h-MSC Expansion and Their Functional Characteristics. Ann Biomed Eng. 2020;48(2):519-535.
[22] MOLL G, DRZENIEK N, KAMHIEH-MILZ J, et al. MSC Therapies for COVID-19: Importance of Patient Coagulopathy, Thromboprophylaxis, Cell Product Quality and Mode of Delivery for Treatment Safety and Efficacy. Front Immunol. 2020;11:1091.
[23] DING C, ZOU Q, WANG F, et al. Human amniotic mesenchymal stem cells improve ovarian function in natural aging through secreting hepatocyte growth factor and epidermal growth factor. Stem Cell Res Ther. 2018;9(1):55.
[24] BHARTIYA D, JAMES K. Very small embryonic-like stem cells (VSELs) in adult mouse uterine perimetrium and myometrium. J Ovarian Res. 2017;10(1):29.
[25] XIE Q, XIONG X, XIAO N, et al. Mesenchymal Stem Cells Alleviate DHEA-Induced Polycystic Ovary Syndrome (PCOS) by Inhibiting Inflammation in Mice. Stem Cells Int. 2019;2019:9782373.
[26] YIN N, WANG Y, LU X, et al. hPMSC transplantation restoring ovarian function in premature ovarian failure mice is associated with change of Th17/Tc17 and Th17/Treg cell ratios through the PI3K/Akt signal pathway. Stem Cell Res Ther. 2018;9(1):37.
[27] HUANG B, QIAN C, DING C, et al. Fetal liver mesenchymal stem cells restore ovarian function in premature ovarian insufficiency by targeting MT1. Stem Cell Res Ther. 2019;10(1):362.
[28] YIN N, WU C, QIU J, et al. Protective properties of heme oxygenase-1 expressed in umbilical cord mesenchymal stem cells help restore the ovarian function of premature ovarian failure mice through activating the JNK/Bcl-2 signal pathway-regulated autophagy and upregulating the circulating of CD8+CD28- T cells. Stem Cell Res Ther. 2020;11(1):49.
[29] HUANG B, LU J, DING C, et al. Exosomes derived from human adipose mesenchymal stem cells improve ovary function of premature ovarian insufficiency by targeting SMAD. Stem Cell Res Ther. 2018;9(1):216.
[30] WANG D, WENG Y, ZHANG Y, et al. Exposure to hyperandrogen drives ovarian dysfunction and fibrosis by activating the NLRP3 inflammasome in mice. Sci Total Environ. 2020;745:141049.
[31] RAO PD, SANKRITYAYAN H, SRIVASTAVA A, et al. ‘PARP’ing fibrosis: repurposing poly (ADP ribose) polymerase (PARP) inhibitors. Drug Discov Today. 2020;25(7):1253-1261.
[32] YU M, LIU J. MicroRNA-30d-5p promotes ovarian granulosa cell apoptosis by targeting Smad2. Exp Ther Med. 2020;19(1):53-60.
[33] SUN B, MA Y, WANG F, et al. miR-644-5p carried by bone mesenchymal stem cell-derived exosomes targets regulation of p53 to inhibit ovarian granulosa cell apoptosis. Stem Cell Res Ther. 2019;10(1):360.
[34] SANTORO M, AWOSIKA TO, SNODDERLY KL, et al. Endothelial/Mesenchymal Stem Cell Crosstalk Within Bioprinted Cocultures. Tissue Eng Part A. 2020;26(5-6):339-349. |